Article info
PDFTest yourself
A tough one to swallow
- Correspondence to Dr Eoin Mulroy, Department of Neurology, Auckland City Hospital, Auckland 1023, New Zealand; EoinM{at}adhb.govt.nz
Citation
A tough one to swallow
Publication history
- Accepted February 10, 2018
- First published March 22, 2018.
Online issue publication
June 01, 2018
Article Versions
- Previous version (18 May 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Autoantibody testing in idiopathic inflammatory myopathies
- Evaluation and treatment of inflammatory myopathies
- SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies
- Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort
- Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups
- Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies
- Treatment of myopathy and cutaneous ulcers in anti-MDA5-positive dermatomyositis with triple therapy
- The EuroMyositis registry: an international collaborative tool to facilitate myositis research
- Hyperacute muscle weakness in an unusual coexistence of antisignal recognition particle and anti-Mi-2 antibodies
- Proximal myopathy: diagnostic approach and initial management